Enzo Zamparelli
Overview
Explore the profile of Enzo Zamparelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cesaro C, Masi U, Pedicelli I, Lucci R, Cesaro F, Amore D, et al.
Monaldi Arch Chest Dis
. 2024 May;
PMID: 38722173
Benign endobronchial tumors are rare clinical entities characterized by considerable variability in etiology and clinical presentation. The authors report four cases of endobronchial hamartomas treated and followed up from 2018...
2.
Cesaro C, Caterino U, Rossi F, Masi U, Perrotta F, Zamparelli E, et al.
J Bronchology Interv Pulmonol
. 2023 Sep;
31(1):88-90.
PMID: 37735757
No abstract available.
3.
Cesaro C, Caterino U, Perrotta F, Masi U, Cotroneo A, Cianci R, et al.
Monaldi Arch Chest Dis
. 2022 Sep;
93(3).
PMID: 36128929
Alectinib is a highly selective tyrosine kinase inhibitor of anaplastic lymphoma kinase (ALK) that is approved as first-line treatment in adult patients with ALK-positive non-small cell lung cancer (NSCLC) and...
4.
Caterino U, Amore D, Cesaro C, Zamparelli E, Cesaro F, Palma A, et al.
Case Rep Oncol
. 2022 May;
15(1):300-304.
PMID: 35529285
We report an unusual mediastinal recurrence along descending thoracic aorta during oncologic follow-up in a 47-year-old female smoker issued by lung adenocarcinoma with a history of left lower lobectomy and...
5.
Caterino U, Cesaro C, Zamparelli E, Cesaro F, Palma A, Lucci R, et al.
Case Rep Oncol
. 2021 Dec;
14(3):1616-1620.
PMID: 34950005
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%. We describe...
6.
Guarino C, Cesaro C, La Cerra G, Lucci R, Cesaro F, Zamparelli E, et al.
Monaldi Arch Chest Dis
. 2021 Dec;
92(3).
PMID: 34918499
Pulmonary hamartomas represent the most frequent family of benign lung tumors that typically involve the lung parenchyma and only rarely grow as endobronchial tumors. The elective treatment of endobronchial hamartoma...
7.
Guarino C, Cesaro C, La Cerra G, Lucci R, Cesaro F, Zamparelli E
Tumori
. 2021 Jun;
107(6):NP91-NP93.
PMID: 34134548
Malignant central airway obstruction is a life-threatening condition that often causes respiratory failure. In many cases, treatment of tumor in rigid bronchoscopy must be performed urgently, soothing respiratory symptoms and...
8.
Guarino C, Cesaro C, Fiorentino G, Rossi F, Polverino B, Fragranza F, et al.
Monaldi Arch Chest Dis
. 2021 Mar;
91(2).
PMID: 33666070
Severe Acute Respiratory Syndrome due to Coronavirus-19 (SARS-CoV-2) is caused by combined alveolar-capillary lung damage, with bilateral pneumonia and thrombosis, which often causes respiratory failure. Proper COVID-19 management requires high...
9.
Zamparelli E, Fiorelli A, La Cerra G, Guarino C, Santoriello E, Buono S, et al.
Minerva Anestesiol
. 2019 Apr;
85(7):756-762.
PMID: 30938120
Background: The aim of this study was to evaluate the use of laryngeal mask airway (LMA)® Protector™ by comparison with traditional LMA for performing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)....